Search

everythinglearnresearchcommunity

for

Search:↓

Low prolactin in young women may increase heart and metabolism risks.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

A postmenopausal woman's hirsutism and high testosterone levels improved after surgery for an ovarian tumor not seen on ultrasound.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Women with acne have lower levels of a specific hormone marker than women without acne.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Women with hair loss had lower IGF-1 levels.

Healthcare providers should know how to manage facial hair issues in women due to their social impact.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

A holistic approach, including medical treatments, lifestyle changes, and mental health support, is crucial for managing hirsutism in women.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Finasteride improves hair loss in women with hyperandrogenism.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.